Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Gray Sheet

Executive Summary

Israeli firm plans to submit by early 2002 a 510(k) for peripheral arterial tone (PAT) technology for sleep apnea and endothelial function. Trials for both indications are under way in the U.S., Europe and Israel. Technology is used to monitor peripheral vascular responses to autonomic nervous system activity. Separately, approval of firm's ETT_PAT 2000 for use in cardiac stress testing for the detection of myocardial ischemia is announced April 4. Future potential indications include early diagnosis of hypertension, evaluation of cardiovascular status in diabetics



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts